US Stocks
/
Gossamer Bio, Inc. Share Price

Gossamer Bio, Inc. Share Price

NASDAQ: GOSS | Micro Cap
$0.18
+$0.00 (0.39%) Last updated on 08 Aug, 2026 | 01:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Gossamer Bio, Inc. Stock Performance

Open
$0.18
Prev. Close
$0.18
Circuit Range
N/A
Day Range
$0.17 - $0.18
Year Range
$0.11 - $3.87
Volume
1,27,428
Average Traded
$0.18

Gossamer Bio, Inc. Share Price Today

As of 10 August 2026, Gossamer Bio, Inc.'s share price is $0.18. The stock opened at $0.18, compared to its previous close of $0.18. During today's trading session, Gossamer Bio, Inc.'s share price traded between $0.17 and $0.18, with an average price of $0.18. Over the past 52 weeks, the stock has recorded a high of $3.87 and a low of $0.11. In terms of performance, Gossamer Bio, Inc.'s share price has declined by 58.21% over the last six months and is down 92.76% on a year-on-year basis.

Gossamer Bio, Inc. Share Price Chart

$0.17$0.18
L
Show Current Price
H

Gossamer Bio, Inc. Stock Fundamentals & Key Indicators

Market Cap
$40.97M
PE Ratio (TTM)
-0.24
Dividend Yield
N/A
EPS (TTM)
$-0.75
Revenue (TTM)
$48.47M
Return On Equity (TTM)
138.78%
Profit Margin
-351.49%
Debt to Equity
-0.52
Quarterly Earnings Growth YoY
-56.55%

Gossamer Bio, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsMar 2024Jun 2024Sep 2024Mar 2025Jun 2025Sep 2025
RevenueN/A$95.84M$9.48M$9.89M$11.49M$13.29M
Net Profit-$41.93M$49.23M-$30.80M-$36.64M-$38.27M-$48.22M
Net Profit MarginN/A51.37%-324.93%-370.49%-333.13%-362.73%
Income ChangeN/A217.42%-162.57%-18.94%-4.46%-25.99%

Gossamer Bio, Inc. Annual Profit & Loss

All figures in USD

Particulars20212022202320242025
RevenueN/AN/AN/A$114.70M$48.47M
Net Profit-$234.00M-$229.38M-$179.82M-$56.53M-$170.37M
Net Profit MarginN/AN/AN/A-49.28%-351.49%
Income ChangeN/A1.98%21.61%68.56%-201.39%

About Gossamer Bio, Inc.

Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing seralutinib for the treatment of pulmonary arterial hypertension (PAH) in the United States. The company is developing GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colony-stimulatin factor 1 receptor and c-KIT inhibitor, which is in Phase 3 clinical trial for the treatment of PAH. It has license agreements with Pulmokine, Inc. to develop and commercialize GB002 and related backup compounds. The company was formerly known as FSG, Bio, Inc. and changed its name to Gossamer Bio, Inc. in 2017. The company was incorporated in 2015 and is headquartered in San Diego, California.

Gossamer Bio, Inc. Historical Returns

MonthOpenCloseChange %
Aug 2026
$0.16
$0.18
+6.55%
Jul 2026
$0.16
$0.17
+0.60%
Jun 2026
$0.23
$0.17
-24.77%
May 2026
$0.35
$0.22
-39.67%
Apr 2026
$0.33
$0.37
+11.18%
Mar 2026
$0.41
$0.33
-22.84%
Feb 2026
$2.29
$0.43
-81.10%
Jan 2026
$3.12
$2.27
-27.01%
Dec 2025
$3.24
$3.11
-6.75%
Nov 2025
$2.43
$3.33
+35.57%
Oct 2025
$2.60
$2.46
-6.29%
Sep 2025
$2.43
$2.63
+6.06%

GOSS Share Price FAQs

What is Gossamer Bio, Inc. share price today?

chevron-up
Gossamer Bio, Inc. share price today is $0.18 as on August 8, 2026 at 1:29 am IST.

What is the 52 week high and 52 week low of Gossamer Bio, Inc. stock?

chevron-up
The 52 week high of Gossamer Bio, Inc. stock is $3.87, while the 52 week low is $0.11 as of 8 Aug '26.

What is GOSS's market capitalisation today?

chevron-up
GOSS market capitalisation is $40.97M as of August 10, 2026, at 1:34 pm IST.

What is GOSS's net income for the last quarter?

chevron-up
GOSS's net income for the last quarter is -0.05B USD.

What is the 5 year returns of GOSS?

chevron-up
The 5 year returns of GOSS is -98.20% as on 8 Aug '26.

What is the high & low stock price of GOSS today?

chevron-up
GOSS stock price hit a high of $0.18 and low of $0.17 as of 8 Aug '26.

Can I buy GOSS shares in India?

chevron-up
Yes. You can buy GOSS in India by opening an international trading account.